Product Information
MOVANTIK 25 MG TABLET is a brand product labeled by RedHill Biopharma Ltd, priced at $14.5943 per EA under NDC 57841130103. Its NADAC has been published 306 times since Nov 4, 2020.
FDA first approved this application on Sep 16, 2014.
Strength
25 mg/1
Manufacturer
RedHill Biopharma LtdNDC
57841130103
Classification
Brand
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
NALOXEGOL OXALATEApproval Type
New Drug (NDA)
FDA Application
NDA204760FDA Approved
9/16/2014
On Market Since
10/1/2020
Pharmacological Classes
Price Statistics
The NADAC for MOVANTIK 25 MG TABLET has been published 306 times since Nov 4, 2020, and over the history we have for it it has risen 28.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $14.5943 per EA |
|---|---|
| All-time high | $14.6309 (May 13, 2026) |
| All-time low | $11.3314 (Dec 23, 2020) |
| 52-week high | $14.6309 |
| 52-week low | $13.9309 |
| Median price | $12.6140 |
| Average price | $12.9186 |
| Largest weekly change | +5.0% (Jan 1, 2025) |
| Weeks tracked | 306 |
| Tracking since | Nov 4, 2020 |
1W
N/A
1M
0.0%
3M
-0.1%
6M
-0.2%
1Y
+4.8%
3Y
+15.7%
5Y
+25.1%
All
+28.2%
Last surveyed Sep 9, 2026 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
RedHill Biopharma Ltd manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
naloxegol oxalate market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Opioid Antagonist class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of MOVANTIK 25 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for MOVANTIK 25 MG TABLET, manufactured by RedHill Biopharma Ltd, is $14.5943 per EA (NDC 57841130103), effective Sep 9, 2026.
How has the price of MOVANTIK 25 MG TABLET changed over time?
Over the history we have for it, the NADAC for MOVANTIK 25 MG TABLET has risen 28.2%. It has been tracked across 306 weekly CMS publications since Nov 4, 2020.
What are the highest and lowest recorded NADAC prices for MOVANTIK 25 MG TABLET?
Since Nov 4, 2020, the NADAC for MOVANTIK 25 MG TABLET has ranged from a low of $11.3314 (Dec 23, 2020) to a high of $14.6309 (May 13, 2026), with a median of $12.6140 per EA.
Are there cheaper alternatives to MOVANTIK 25 MG TABLET?
2 manufacturers publish a NADAC-priced product with the same active ingredient and strength as MOVANTIK 25 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures MOVANTIK 25 MG TABLET?
MOVANTIK 25 MG TABLET (NDC 57841130103) is labeled by RedHill Biopharma Ltd, and CMS classifies it as a brand product.